HappeningToo topic
Adalimumab reports
Browse community reports connected to Adalimumab. These reports can show that other people are describing similar experiences, but they do not prove that Adalimumab caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
29 problems
Abdominal Discomfort while using Adalimumab
FDA FAERS contains adverse-event reports in which Adalimumab and abdominal discomfort appear together. This does not establish that Adalimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain Upper while using Adalimumab
FDA FAERS contains adverse-event reports in which Adalimumab and abdominal pain upper appear together. This does not establish that Adalimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain while using Adalimumab
FDA FAERS contains adverse-event reports in which Adalimumab and abdominal pain appear together. This does not establish that Adalimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Alopecia while using Adalimumab
FDA FAERS contains adverse-event reports in which Adalimumab and alopecia appear together. This does not establish that Adalimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Anxiety while using Adalimumab
FDA FAERS contains adverse-event reports in which Adalimumab and anxiety appear together. This does not establish that Adalimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Adalimumab
FDA FAERS contains adverse-event reports in which Adalimumab and back pain appear together. This does not establish that Adalimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Adalimumab
FDA FAERS contains adverse-event reports in which Adalimumab and cough appear together. This does not establish that Adalimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Adalimumab
FDA FAERS contains adverse-event reports in which Adalimumab and decreased appetite appear together. This does not establish that Adalimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Adalimumab
FDA FAERS contains adverse-event reports in which Adalimumab and diarrhea appear together. This does not establish that Adalimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Adalimumab
FDA FAERS contains adverse-event reports in which Adalimumab and dizziness appear together. This does not establish that Adalimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Adalimumab
FDA FAERS contains adverse-event reports in which Adalimumab and fatigue appear together. This does not establish that Adalimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Feeling Abnormal while using Adalimumab
FDA FAERS contains adverse-event reports in which Adalimumab and feeling abnormal appear together. This does not establish that Adalimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Adalimumab
FDA FAERS contains adverse-event reports in which Adalimumab and headache appear together. This does not establish that Adalimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hives while using Adalimumab
FDA FAERS contains adverse-event reports in which Adalimumab and hives appear together. This does not establish that Adalimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Adalimumab
FDA FAERS contains adverse-event reports in which Adalimumab and insomnia appear together. This does not establish that Adalimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Adalimumab
FDA FAERS contains adverse-event reports in which Adalimumab and itching appear together. This does not establish that Adalimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Adalimumab
FDA FAERS contains adverse-event reports in which Adalimumab and malaise appear together. This does not establish that Adalimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscle Spasms while using Adalimumab
FDA FAERS contains adverse-event reports in which Adalimumab and muscle spasms appear together. This does not establish that Adalimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Adalimumab
FDA FAERS contains adverse-event reports in which Adalimumab and nausea appear together. This does not establish that Adalimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Adalimumab
FDA FAERS contains adverse-event reports in which Adalimumab and pain appear together. This does not establish that Adalimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Adalimumab
FDA FAERS contains adverse-event reports in which Adalimumab and rash appear together. This does not establish that Adalimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Adalimumab
FDA FAERS contains adverse-event reports in which Adalimumab and shortness of breath appear together. This does not establish that Adalimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Skin redness while using Adalimumab
FDA FAERS contains adverse-event reports in which Adalimumab and skin redness appear together. This does not establish that Adalimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Swelling while using Adalimumab
FDA FAERS contains adverse-event reports in which Adalimumab and swelling appear together. This does not establish that Adalimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tingling or pins and needles while using Adalimumab
FDA FAERS contains adverse-event reports in which Adalimumab and tingling or pins and needles appear together. This does not establish that Adalimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Adalimumab
FDA FAERS contains adverse-event reports in which Adalimumab and vomiting appear together. This does not establish that Adalimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Adalimumab
FDA FAERS contains adverse-event reports in which Adalimumab and weakness appear together. This does not establish that Adalimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Adalimumab
FDA FAERS contains adverse-event reports in which Adalimumab and weight decreased appear together. This does not establish that Adalimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Adalimumab
FDA FAERS contains adverse-event reports in which Adalimumab and weight increased appear together. This does not establish that Adalimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →